Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
588.99
491.73
398.20
214.20
140.83
119.07
102.31
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
588.99
491.73
398.20
214.20
140.83
119.07
102.31
Raw Material Cost
124.75
106.22
84.53
34.39
21.88
17.04
14.76
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
193.75
177.74
133.71
58.18
49.63
44.23
36.88
Other Expenses
1.27
1.26
9.31
1.98
1.69
1.65
1.88
Total Expenditure (Excl Depreciation)
331.21
296.61
311.39
112.36
88.45
77.77
70.48
Operating Profit (PBDIT) excl Other Income
257.8
195.10000000000002
86.8
101.8
52.400000000000006
41.3
31.8
Other Income
24.77
16.06
7.70
2.88
0.28
0.59
1.49
Operating Profit (PBDIT)
320.71
249.24
127.65
106.20
53.15
42.78
33.61
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
0.97
5.08
0.00
0.00
0.00
0.00
0.10
Gross Profit (PBDT)
464.24
385.51
313.67
179.81
118.95
102.03
87.55
Depreciation
38.17
38.05
33.14
1.49
0.48
0.89
0.30
Profit Before Tax
283.51
216.26
94.51
104.72
52.67
41.89
33.41
Tax
69.19
52.37
23.10
21.64
13.19
-33.09
1.53
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
214.33
163.89
71.41
83.08
39.48
74.98
31.88
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
214.33
163.89
71.41
83.08
39.48
74.98
31.88
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
214.33
163.89
71.41
83.08
39.48
74.98
31.88
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
954.27
727.63
387.88
300.42
206.83
169.60
87.63
Earnings per share (EPS)
1.68
1.31
0.63
0.75
0.37
0.71
0.3
Diluted Earnings per share
1.68
1.31
0.63
0.75
0.37
0.71
0.3
Operating Profit Margin (Excl OI)
43.77%
39.68%
21.8%
47.54%
37.2%
34.69%
31.11%
Gross Profit Margin
54.62%
51.72%
32.06%
49.58%
37.74%
35.92%
32.95%
PAT Margin
36.39%
33.33%
17.93%
38.79%
28.03%
62.97%
31.16%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 19.79% vs 23.48% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 30.75% vs 129.55% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 26.89% vs 94.33% in Dec 2024
Interest
No Interest in the last few periods
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Catalyst Pharmaceuticals, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
588.99
54.03
534.96
990.12%
Other Operating Income
0.00
0.00
0.00
Total Operating income
588.99
54.03
534.96
990.12%
Raw Material Cost
124.75
11.52
113.23
982.90%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
193.75
180.28
13.47
7.47%
Other Expenses
1.27
33.44
-32.17
-96.20%
Total Expenditure (Excl Depreciation)
331.21
526.16
-194.95
-37.05%
Operating Profit (PBDIT) excl Other Income
257.78
-472.13
729.91
154.60%
Other Income
24.77
58.34
-33.57
-57.54%
Operating Profit (PBDIT)
320.71
-408.62
729.33
178.49%
Interest
0.00
0.00
0.00
Exceptional Items
0.97
0.00
0.97
Gross Profit (PBDT)
464.24
42.51
421.73
992.07%
Depreciation
38.17
5.18
32.99
636.87%
Profit Before Tax
283.51
-413.80
697.31
168.51%
Tax
69.19
-1.02
70.21
6,883.33%
Provisions and contingencies
0
0
0.00
Profit After Tax
214.33
-412.78
627.11
151.92%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
214.33
-412.78
627.11
151.92%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
214.33
-412.78
627.11
151.92%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
954.27
1,193.11
-238.84
-20.02%
Earnings per share (EPS)
1.68
-7.12
8.80
123.60%
Diluted Earnings per share
1.68
-7.12
8.80
123.60%
Operating Profit Margin (Excl OI)
43.77%
-873.87%
0.00
917.64%
Gross Profit Margin
54.62%
-756.31%
0.00
810.93%
PAT Margin
36.39%
-764.01%
0.00
800.40%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 58.90 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 19.79% vs 23.48% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 21.43 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 30.75% vs 129.55% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 29.59 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 26.89% vs 94.33% in Dec 2024
Annual - Interest
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 43.77%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
